Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
- Press releaseNov 7, 2024
Reported sales increased 0.4% to $2.082 billion; organic sales increased 0.3% GAAP Earnings Per Share (EPS) of $0.70; adjusted EPS1 of $1.64 Generated $169 million in cash from operations; free...
- Press releaseOct 15, 2024
Solventum (NYSE: SOLV) will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets close. The company will also host a conference call that...
- Press releaseOct 14, 2024
Solventum (NYSE: SOLV), formerly 3M Health Care, today pledges to use 100% renewable electricity across its worldwide operations by 2030. This move highlights Solventum's commitment to...
- Press releaseOct 10, 2024
Solventum (NYSE: SOLV) announced today that Dr. Ryan Egeland, MD, has been named chief medical officer. Dr. Egeland is responsible for leading Solventum's Global Medical and Clinical Affairs team,...
- Press releaseAug 28, 2024
Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences: 2024 Wells Fargo Healthcare Conference in Everett, MA on Wednesday, September 4, 2024 at 11:00 a.m. ET....
- Press releaseAug 20, 2024
Solventum (NYSE: SOLV), formerly 3M Health Care, today announced that its autonomous coding solution has received Toolbox designation from Epic in the Fully Autonomous Coding category. Toolbox is...
- Press releaseAug 8, 2024
Separation activities and business continuity on track Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3% GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56...
- Press releaseJul 16, 2024Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday, August 8, 2024 after the U.S. financial markets close. The company will also host a conference call that...
- Press releaseJun 7, 2024
Solventum (NYSE: SOLV) has been notified that TRC Capital Investment Corporation ("TRC") made an unsolicited "mini-tender offer" to purchase up to 2,000,000 shares of the company's common stock at...
- Press releaseMay 9, 2024
Completed spin-off from 3M and began trading on April 1, 2024 Reported sales increased 0.2% to $2.016 billion, organic sales increased 0.9% GAAP Earnings Per Share (EPS) of $1.37; adjusted EPS1 of...
- Press releaseApr 23, 2024
Solventum (NYSE: SOLV) announced today that it will release carve-out financial results for the first quarter 2024 before the market opens on May 9, 2024. The earnings press release and...
- Press releaseApr 15, 2024
Solventum (NYSE: SOLV) announced today that its Board of Directors appointed Shirley Edwards, former partner, EY, to the board. Edwards will serve on Solventum's Audit and Talent committees, effective
- Press releaseApr 1, 2024
Formerly 3M Health Care Business, Solventum (NYSE: SOLV) enables better, smarter, safer healthcare to improve lives ST. PAUL, Minn., April 1, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced...
- Press releaseMar 19, 2024
- Leadership to highlight opportunity to unlock significant value creation over time - - Solventum to introduce full-year 2024 guidance - ST. PAUL, Minn., March 19, 2024 /PRNewswire/ -- Solventum...
- Press releaseMar 8, 2024
Record date set for March 18, 2024 and distribution date set for April 1, 2024 ST. PAUL, Minn., March 8, 2024 /PRNewswire/ -- 3M (NYSE: MMM) today announced that its Board of Directors has...
- Press releaseFeb 21, 2024
3M (NYSE: MMM) today announced the filing of a Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC) for the planned spin-off of its Health Care business as the...
- Press releaseNov 16, 2023
ST. PAUL, Minn., Nov. 16, 2023 — 3M (NYSE: MMM) today announced Solventum will be the name of the planned, independent health care company following its spin-off. Solventum originates from two...
- Press releaseNov 9, 2023
3M (NYSE: MMM) today announced two leadership changes. In conjunction with the planned spin-off of the Health Care Business, we are announcing the departure of Jeff Lavers, group president, Health...
- Press releaseOct 5, 2023
Wayde McMillan will join 3M’s Health Care Business Group to serve as chief financial officer effective Nov. 1. McMillan joins 3M from Insulet, an innovative medical device company improving the...
- Press releaseAug 22, 2023
3M today announced the appointment of Bryan C. Hanson as Chief Executive Officer of the independent health care company when it is spun off from 3M. Hanson will join 3M on September 1 as CEO of...
- Press releaseMay 31, 2023
Applying its leadership in biopharma filtration technology, 3M (NYSE: MMM) today announced it will invest $146 million dollars to expand its capabilities to further support biotech manufacturing,...
- Press releaseApr 27, 2023
Innovative therapy shown to help promote healing and reduce the need for surgical debridements creating potential savings for health care systems. ST. PAUL, Minn., April 27, 2023 /PRNewswire/ --...
- Press releaseApr 18, 2023
3M Health Information Systems (HIS) announces a collaboration with Amazon Web Services (AWS) to accelerate the innovation and advancement of 3M M*Modal ambient intelligence. As part of the...
- Press releaseDec 12, 2022
3M Health Information Systems (HIS) today announced that U.S. News & World Report is evaluating its new 3M™ Ambulatory Potentially Preventable Complications (3M AM-PPC) software for potential...
- Press releaseNov 17, 2022
3M Health Information Systems (HIS) today announced the rollout of its new methodology, 3M™ Ambulatory Potentially Preventable Complications (3M AM-PPCs) software, developed to address patient...
These contacts are intended only for the media. If you are not a member of the media, please call 1-855-423-6725 (1-855-HC FOR ALL).